U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2

U0005 is an HCPCS Level II code in the U series (coronavirus diagnostic panel and lab services), describing infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2.

It was added to HCPCS effective 01/01/2021, and its current record took effect 05/12/2023.

It was terminated on 05/11/2023 and can't be billed for later dates of service.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.